Preclinical Evaluation of hnRNPA2B1 Antibody in Human Triple-Negative Breast Cancer MDA-MB-231 Cells via PET Imaging

• Príomhchruthaitheoirí: Abhinav Bhise (Údar), Hyun Park (Údar), Woonghee Lee (Údar), Swarbhanu Sarkar (Údar), Yeong Su Ha (Údar), Subramani Rajkumar (Údar), Bora Nam (Údar), Jeong Eun Lim (Údar), Phuong Tu Huynh (Údar), Kiwoong Lee (Údar), Ji-Yoon Son (Údar), Jung Young Kim (Údar), Kyo Chul Lee (Údar), Jeongsoo Yoo (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: MDPI AG, 2022-08-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Triple-negative breast cancer (TNBC) does not express estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2. Because TNBC lacks the expression of commonly targeted receptors, it is challenging to develop a new imaging agent for this cancer subtype. Heterogeneous nucl...